Coherus Oncology, Inc.
CHRS· Nasdaq
Coherus Oncology, Inc.
- Last sale
- Oct 1, 2026 · -3.77%
- Market cap
- $177.68M
- 154.5M shares
- Filings
- 920
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2018 | 2018-12-31 | $0 | reported | |
| FY 2017 | 2017-12-31 | $1,556,000 | reported | |
| FY 2016 | 2016-12-31 | $190,106,000 | reported | |
| FY 2015 | 2015-12-31 | $30,041,000 | reported | |
| FY 2014 | 2014-12-31 | $31,106,000 | reported | |
| FY 2013 | 2013-12-31 | $2,751,000 | reported | |
| FY 2012 | 2012-12-31 | $1,899,000 | reported |
Coherus Oncology, Inc. · CIK 1512762 · Engraved from SEC EDGAR
